FindMyKOL
Clinical trialNCT00570440CompletedPhase 4Interventional

Continuous Use of COCs

SponsorFHI 360Enrollment362Pregnancy Prevention
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective is to determine if continuous COC use leads to higher continuation rates over 12 months of follow up than use of the standard 28-day COC regimen.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Dominican Republic
  • Profamilia - Santo Domingo, Dominican Republic

    Ens. Luperon, Santo Domingo Province, Dominican Republic

Nicaragua
  • Profamilia - Managua, Nicaragua

    Managua, Managua Department, Nicaragua

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Oral contraceptives--ethinyl estradiol, levonorgestrel
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2007
Primary completion
31 Oct 2010
Completion
31 Oct 2010
Last update posted
31 Oct 2011
Registered enrollment
362
Registry id
NCT00570440
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.